Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Avadel Pharmaceuticals PLC changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 156 | 1 | 176 | +21 |
| Shares | 74.0M | 4.82M | 74.7M | +5.47M (+7.9%) |
| Value | $1.04B | $67.7M | $979.2M | +$8.06M (+0.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (25)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (1)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,816,743 | $67.7M |